Constitutive and Induced CD44 Shedding by ADAM-Like Proteases and Membrane-Type 1 Matrix Metalloproteinase

No abstract is available for this paper.

• Publication year

  2004

• Venue

  Cancer Research

• Publication date

  2004-02-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1158/0008-5472.CAN-03-3502PMID 14871815
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Measurement of an adhesion molecule as an indicator of inflammatory disease activity. Up-regulation of the receptor for hyaluronate (CD44) in rheumatoid arthritis.

  2010cited by this paper
• Serum levels of soluble CD44 variant isoforms are elevated in rheumatoid arthritis

  2005cited by this paper
• Membrane-type 1 matrix metalloproteinase: a key enzyme for tumor invasion.

  2003cited by this paper
• Sequence-specific silencing of MT1-MMP expression suppresses tumor cell migration and invasion: importance of MT1-MMP as a therapeutic target for invasive tumors

  2003influential reference
• Roles of pericellular proteolysis by membrane type‐1 matrix metalloproteinase in cancer invasion and angiogenesis

  2003cited by this paper
• Monoclonal antibodies with defined recognition sequences in the stem region of CD44: detection of differential glycosylation of CD44 between tumor and stromal cells in tissue.

  2003influential reference
• Role of pericellular proteolysis by membrane-type 1 matrix metalloproteinase in cancer invasion and angiogenesis

  2003cited by this paper
• CD44: From adhesion molecules to signalling regulators

  2003influential reference
• The cell surface: the stage for matrix metalloproteinase regulation of migration.

  2002cited by this paper
• Targeting angiogenesis and HGF function using an adenoviral vector expressing the HGF antagonist NK4 for cancer therapy.

  2002cited by this paper
• CD44 directs membrane‐type 1 matrix metalloproteinase to lamellipodia by associating with its hemopexin‐like domain

  2002cited by this paper
• CD44 anchors the assembly of matrilysin/MMP-7 with heparin-binding epidermal growth factor precursor and ErbB4 and regulates female reproductive organ remodeling.

  2002cited by this paper
• New functions for the matrix metalloproteinases in cancer progression

  2002cited by this paper
• Metalloproteinase inhibitors: biological actions and therapeutic opportunities

  2002cited by this paper
• Proteolytic cleavage of the CD44 adhesion molecule in multiple human tumors.

  2002cited by this paper
• Determination of protease cleavage site motifs using mixture-based oriented peptide libraries

  2001cited by this paper
• Osteopontin, a Novel Substrate for Matrix Metalloproteinase-3 (Stromelysin-1) and Matrix Metalloproteinase-7 (Matrilysin)*

  2001cited by this paper
• Membrane-Type 1 Matrix Metalloproteinase Cleaves Cd44 and Promotes Cell Migration

  2001influential reference
• Hyaluronan: a multifunctional, megaDalton, stealth molecule.

  2000cited by this paper
• Regulation of membrane type-1 matrix metalloproteinase activation by proprotein convertases.

  2000cited by this paper
• Cell surface-localized matrix metalloproteinase-9 proteolytically activates TGF-beta and promotes tumor invasion and angiogenesis.

  2000cited by this paper
• Administration of wild-type p53 adenoviral vector synergistically enhances the cytotoxicity of anti-cancer drugs in human lung cancer cells irrespective of the status of p53 gene.

  2000cited by this paper
• Localization of matrix metalloproteinase 9 to the cell surface provides a mechanism for CD44-mediated tumor invasion.

  1999cited by this paper
• Soluble CD44: quantification and molecular repartition in plasma of patients with colorectal cancer

  1999cited by this paper
• Generation of Artificial Proteoglycans Containing Glycosaminoglycan-modified CD44

  1999cited by this paper
• Soluble CD44 Variant 6 as a Prognostic Indicator in Patients with Colorectal Cancer

  1999cited by this paper
• CD44 cleavage induced by a membrane-associated metalloprotease plays a critical role in tumor cell migration

  1999cited by this paper
• Anti-Tumor Immunity Induced by in Vivo Adenovirus Vector-Mediated Expression of CD40 Ligand in Tumor Cells

  1999cited by this paper
• Proteolytic processing of membrane-type-1 matrix metalloproteinase is associated with gelatinase A activation at the cell surface.

  1998cited by this paper
• Increased serum levels of soluble CD44-isoform v5 in rheumatic diseases are restricted to seropositive rheumatoid arthritis.

  1997cited by this paper
• CD44: structure, function, and association with the malignant process.

  1997cited by this paper
• Enhanced production of matrix metalloproteinases and activation of matrix metalloproteinase 2 (gelatinase A) in human gastric carcinomas

  1996cited by this paper
• Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors.

  1996cited by this paper
• Potential use of soluble CD44 in serum as indicator of tumor burden and metastasis in patients with gastric or colon cancer.

  1994cited by this paper
• CD44 is the principal cell surface receptor for hyaluronate.

  1990cited by this paper

• The bronchoalveolar lavage fluid CD44 as a marker for pulmonary fibrosis in diffuse parenchymal lung diseases

  2025cites this paper
• Evaluation of Endothelial Glycocalyx Damage in Neonatal Lambs With Diarrhoea: A Biomarker‐Based Approach

  2025cites this paper
• Apoptotic Caspases-3 and -7 Cleave Extracellular Domains of Membrane-Bound Proteins from MDA-MB-231 Breast Cancer Cells

  2025cites this paper
• Matrix metalloproteinases at a glance.

  2024cites this paper
• Cy3 Cyanine Dye with Strong Fluorescence Enhancement for AGRO100 and Its Derivative.

  2023cites this paper
• Dysregulation of ADAM10 shedding activity in naked mole‐rat fibroblasts is due to deficient phosphatidylserine externalization

  2023cites this paper
• Exploring stage‑specific embryonic antigen 3 involvement in oral cancer progression and as a potential target for taxane‑based chemotherapy

  2023cites this paper
• Proteolysis of CD44 at the cell surface controls a downstream protease network

  2023cites this paper
• Castanospermine suppresses CD44 ectodomain cleavage as revealed by transmembrane bioluminescent sensors.

  2022cites this paper
• Tissue Inhibitor of Metalloproteases 3 (TIMP-3): In Vivo Analysis Underpins Its Role as a Master Regulator of Ectodomain Shedding

  2022cites this paper
• Hyaluronan Synthase 3 is Protective After Cardiac Ischemia-Reperfusion by preserving the T cell Response.

  2022cites this paper
• Dysregulation of ADAM10 shedding activity as a mechanism of cancer resistance in the naked mole-rat

  2022influential citation
• Glycoproteogenomics characterizes the CD44 splicing code associated with bladder cancer invasion

  2022cites this paper
• Dysregulation of ADAM10 shedding activity in naked mole-rat fibroblasts is due to deficient phosphatidylserine externalisation

  2022cites this paper
• Altered Extracellular Matrix as an Alternative Risk Factor for Epileptogenicity in Brain Tumors

  2022cites this paper
• A rapid, selective, and ultrasensitive voltammetric and gravimetric protocol for MMP-1 active form detection.

  2022cites this paper
• Scavenger receptors in host defense: from functional aspects to mode of action

  2022cites this paper
• Emerging roles of MT‐MMPs in embryonic development

  2021cites this paper
• Meprin and ADAM proteases as triggers of systemic inflammation in sepsis

  2021cites this paper
• Hyperglycemia-induced effects on glycocalyx components in the retina.

  2021cites this paper
• Proteolytic Processing of CD44 and Its Implications in Cancer

  2021cites this paper
• University of Groningen Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex Bongaarts,

  2020cites this paper
• Cell-surface heparan sulfate proteoglycans as multifunctional integrators of signaling in cancer.

  2020cites this paper
• Targeting the Extra-Cellular Matrix—Tumor Cell Crosstalk for Anti-Cancer Therapy: Emerging Alternatives to Integrin Inhibitors

  2020cites this paper
• Dysregulation of the MMP/TIMP Proteolytic System in Subependymal Giant Cell Astrocytomas in Patients With Tuberous Sclerosis Complex: Modulation of MMP by MicroRNA-320d In Vitro

  2020influential citation
• A Novel Splice Variant of HYAL-4 Drives Malignant Transformation and Predicts Outcome in Patients with Bladder Cancer

  2020cites this paper
• Investigating the Anti-Cancer Properties of Novel Hybrid 1,4-Dihydropyridine Derivatives in U-87MG Glioblastoma Cell

  2019cites this paper
• Matrix Metalloproteases as Influencers of the Cells’ Social Media

  2019cites this paper
• TIMP-3 as a therapeutic target for cancer

  2019cites this paper
• The Expanding Role of MT1-MMP in Cancer Progression

  2019cites this paper
• CD44/CD44v6 a Reliable Companion in Cancer-Initiating Cell Maintenance and Tumor Progression

  2018cites this paper
• A disintegrin and metalloproteinase 15-mediated glycocalyx shedding contributes to vascular leakage during inflammation

  2018cites this paper
• HIF-dependent Signaling Pathways in Cancer

  2017cites this paper
• Matrix‐metalloproteinases as targets for controlled delivery in cancer: An analysis of upregulation and expression

  2017cites this paper
• MicroRNA-655-3p functions as a tumor suppressor by regulating ADAM10 and β-catenin pathway in Hepatocellular Carcinoma

  2016cites this paper
• Ectodomain Shedding of Lymphatic Vessel Endothelial Hyaluronan Receptor 1 (LYVE-1) Is Induced by Vascular Endothelial Growth Factor A (VEGF-A)*

  2016cites this paper
• Mechanical stress loading induces CD44 cleavage in human chondrocytic HCS-2/8 cells.

  2016cites this paper
• ADAM10 Proteases and Pancreatic Cancer

  2016cites this paper
• Pancreatic cancer stem cell markers and exosomes - the incentive push.

  2016cites this paper
• Characterization of CD200 Ectodomain Shedding

  2016cites this paper
• Synthesis of Hyaluronan by Tumour Cells – Mechanism and Implications

  2016cites this paper
• Matrix metalloproteinases in the brain and blood–brain barrier: Versatile breakers and makers

  2016cites this paper
• Fendiline inhibits proliferation and invasion of pancreatic cancer cells by interfering with ADAM10 activation and β-catenin signaling

  2015cites this paper
• CD44, Hyaluronan, the Hematopoietic Stem Cell, and Leukemia-Initiating Cells

  2015cites this paper
• Increased expression of surface CD44 in hypoxia-DCs skews helper T cells toward a Th2 polarization

  2015cites this paper
• ADAM10 controls collagen signaling and cell migration on collagen by shedding the ectodomain of discoidin domain receptor 1 (DDR1)

  2015cites this paper
• CD44 knock-down in bovine and human chondrocytes results in release of bound HYAL2.

  2015cites this paper
• Soluble CD44 concentration in the serum and peritoneal fluid samples of patients with different stages of endometriosis

  2015cites this paper
• Monitoring and Inhibiting MT1-MMP during Cancer Initiation and Progression

  2014cites this paper
• TSPAN2 is involved in cell invasion and motility during lung cancer progression.

  2014cites this paper
• Purification, Characterization and Plasma Half-Life of PEGylated Soluble Recombinant Non-HA-Binding CD44

  2014cites this paper
• Mesenchymal CD44 expression contributes to the acquisition of an activated fibroblast phenotype via TWIST activation in the tumor microenvironment.

  2013cites this paper
• CD44 Integrates Signaling in Stem Cell Microenvironments

  2013cites this paper
• CD200: A Novel Therapeutic Target for Chronic Lymphocytic Leukemia

  2013cites this paper
• Regulation of MT1-MMP Activation and Its Relevance to Disease Processes

  2013cites this paper
• ADAM 10 is the Responsible Sheddase of the CD 44 Ectodomain in Human Melanoma Cells

  2013influential citation
• Membrane Localization of Membrane Type 1 Matrix Metalloproteinase by CD44 Regulates the Activation of Pro-Matrix Metalloproteinase 9 in Osteoclasts

  2013cites this paper
• Intracellular Domain Fragment of CD44 Alters CD44 Function in Chondrocytes*

  2013cites this paper
• CD44 integrates signaling in normal stem cell, cancer stem cell and (pre)metastatic niches

  2013cites this paper
• Autoimmune Inflammation Ligand Galectin-8 in Apoptotic Regulation of The Involvement of CD44 and Its Novel

  2013cites this paper
• Anti-CD44 and Anti-platelet Antibodies have Similar but Distinct Effects in the Treatment of a Mouse Model of Arthritis

  2012cites this paper
• MMP-9 induces CD44 cleavage and CD44 mediated cell migration in glioblastoma xenograft cells.

  2012cites this paper
• The mannose receptor

  2012cites this paper
• The Liberation of CD44 Intracellular Domain Modulates Adenoviral Vector Transgene Expression*

  2012influential citation
• CD44: can a cancer-initiating cell profit from an abundantly expressed molecule?

  2011cites this paper
• shRNA against CD44 inhibits cell proliferation, invasion and migration, and promotes apoptosis of colon carcinoma cells.

  2011cites this paper
• Soluble CD44 Interacts with Intermediate Filament Protein Vimentin on Endothelial Cell Surface

  2011cites this paper
• The Extracellular Matrix as a Multivalent Signaling Scaffold that Orchestrates Tissue Organization and Function

  2011cites this paper
• Serum CD44 levels predict survival in patients with low-risk myelodysplastic syndromes.

  2011cites this paper
• Proteases in Melanoma

  2011cites this paper
• The activity of a designer tissue inhibitor of metalloproteinases (TIMP)-1 against native membrane type 1 matrix metalloproteinase (MT1-MMP) in a cell-based environment.

  2010cites this paper
• The Protein Kinase C Cascade Regulates Recruitment of Matrix Metalloprotease 9 to Podosomes and Its Release and Activation

  2010cites this paper
• Proteolytic and non-proteolytic roles of membrane type-1 matrix metalloproteinase in malignancy.

  2010cites this paper
• Soluble adhesion molecules in human cancers: sources and fates.

  2010cites this paper
• Induction of CD44 cleavage in articular chondrocytes.

  2010cites this paper
• Interference with islet-specific homing of autoreactive T cells: an emerging therapeutic strategy for type 1 diabetes.

  2010cites this paper
• Collagen in Cancer

  2010cites this paper
• The mannose receptor in macrophage biology

  2010cites this paper
• The Wnt/Planar Cell Polarity Protein-tyrosine Kinase-7 (PTK7) Is a Highly Efficient Proteolytic Target of Membrane Type-1 Matrix Metalloproteinase

  2010cites this paper
• ADAM10 is the constitutive functional sheddase of CD44 in human melanoma cells.

  2009cites this paper
• Caractérisation de l'axe MT1-MMP/COX-2 dans les cellules souches cancéreuses CD133(+) de glioblastome

  2009cites this paper
• VORKOMMEN UND PROTEOLYTISCHE REGULATION VON CXCL16 IN DER HAUT

  2009cites this paper
• Hyaluronan in Human Tumors

  2009cites this paper
• Ectodomain shedding of the receptor for advanced glycation end products: a novel therapeutic target for Alzheimer’s disease

  2009cites this paper
• Transforming growth factor-beta induces CD44 cleavage that promotes migration of MDA-MB-435s cells through the up-regulation of membrane type 1-matrix metalloproteinase.

  2009cites this paper
• Characterization of the expression of variant and standard CD44 in prostate cancer cells: Identification of the possible molecular mechanism of CD44/MMP9 complex formation on the cell surface

  2009cites this paper
• α‐Synuclein induces migration of BV‐2 microglial cells by up‐regulation of CD44 and MT1‐MMP

  2009cites this paper
• Identification and Characterization of Lutheran Blood Group Glycoprotein as a New Substrate of Membrane-type 1 Matrix Metalloproteinase 1 (MT1-MMP)

  2009cites this paper
• High throughput analysis of proteins associating with a proinvasive MT1‐MMP in human malignant melanoma A375 cells

  2009cites this paper
• ADAM10 as a therapeutic target for cancer and inflammation.

  2009cites this paper
• Matrix metalloproteinases, T cell homing and beta-cell mass in type 1 diabetes.

  2009cites this paper
• MT1-MMP and RECK are involved in human CD34+ progenitor cell retention, egress, and mobilization.

  2009cites this paper
• Polarized MT1-MMP-CD44 interaction and CD44 cleavage during cell retraction reveal an essential role for MT1-MMP in CD44-mediated invasion.

  2009cites this paper
• Role of Hyaluronan and CD44 in Melanoma Progression

  2009cites this paper
• Hyaluronan in human tumors: pathobiological and prognostic messages from cell-associated and stromal hyaluronan.

  2008cites this paper
• Membrane type 1-matrix metalloproteinase: substrate diversity in pericellular proteolysis.

  2008cites this paper
• Collagens, stromal cell‐derived factor‐1α and basic fibroblast growth factor increase cancer cell invasiveness in a hyaluronan hydrogel

  2008cites this paper
• Molecular signature of MT1-MMP: transactivation of the downstream universal gene network in cancer.

  2008cites this paper
• TLR ligand–induced podosome disassembly in dendritic cells is ADAM17 dependent

  2008cites this paper
• The role of CXCL16 and its processing metalloproteinases ADAM10 and ADAM17 in the proliferation and migration of human mesangial cells.

  2008cites this paper